… The benefits of adding surgery to chemoradiotherapy when compared to
chemoradiotherapy alone for nonmetastatic esophageal cancer are unclear. Definitive …

Objective: We present and analyze long-term outcomes following multimodal therapy for
esophageal cancer, in particular the relative impact of histomorphologic tumor regression and …

… further demonstrates the value of chemoradiotherapy in the treatment of patients who have
esophageal cancer. It seems reasonable to conclude that chemoradiotherapy now should be …

… of esophageal cancer since the beginning of the 20th century. Although the use of radiotherapy
alone to treat esophageal cancer … chemoradiotherapy paradigms for esophageal cancer. …

… role of chemoradiotherapy in the multimodality treatment of esophageal cancer is still
controversial. According to a series of clinical trials, definitive chemoradiotherapy is considered the …

… Controversy currently exists about the optimum preoperative treatment platform for
locoregionally advanced esophageal cancer, namely, preoperative chemoradiotherapy (preoperative …

… Lacking a clinical trial, our approach for managing esophageal cancer has been based on
clinical stage. … Patients thought to have T1N0M0 or T2N0M0 esophageal cancer are offered …

… This study is a retrospective analysis of 62 patients who received chemoradiotherapy for
esophageal cancer from February 2000 to December 2008 at a single tertiary referral center. …

… fact that it is the seventh leading cause of cancer-related death [1]. At present… esophageal
cancer [3,4]. Current neoadjuvant therapy primarily comprises neoadjuvant chemoradiotherapy …

… of studying esophageal cancer independently according to the histopathological types.
Our results suggest that both NCT and NCRT improve overall survival (OS) in esophageal …